Last Updated : December 12, 2011
Details
FilesGeneric Name:
Asenapine
Project Status:
Complete
Therapeutic Area:
Schizophrenia
Manufacturer:
Lundbeck Canada Inc.
Call for patient/clinician input open:
Brand Name:
Saphris
Project Line:
Reimbursement Review
Project Number:
SR0262-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Submission Type:
Initial
Indications:
Schizophrenia
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : December 12, 2011